Publications
5803 Results
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS3620)ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1613
A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (mCRC) with HER2 Amplification: SWOG S1613
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS9597); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1616
Clinical Trial in Progress: Combining ipilimumab (ipi) and nivolumab (nivo) in advanced melanoma following progression on a PD-1 inhibitor (SWOG S1616)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 1551); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
- Year
- 2018
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Case-only analyses for identifying genotypes that modify the effect of finasteride in the Prostate Cancer Prevention Trial (PCPT): SWOG S9217
- Journal / Conference
- Journal of Clinical Oncology Apr 10;36(11):1112-1120; Feb 28 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29489429
- PMC
- PMC5891130
- Study Number(s)
- C89803
Nut consumption and survival in patients with stage III colon cancer: results from CALGB 89803 (Alliance)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 6569); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery
Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 6540); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery
Patient Comorbid Conditions and Cancer Clinical Trial Participation
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr 3570); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Causal modeling of CALGB 80405 identifies network drivers of metastatic colorectal cancer (CRC)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS9599); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
- Year
- 2018
- Research Committee(s)
- Melanoma
- Study Number(s)
- CTSU/A091605
A Randomized Phase II Study of Anti-Pd1 Antibody [Mk-3475 (Pembrolizumab)] Alone Versus Anti-Pd1 Antibody plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr e16107);ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), publication only
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80802
Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB80802 (Alliance) (C8)
- Journal / Conference
- J Clin Oncol 36, 2018 (suppl; abstr TPS4597); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8143